References
- Kleines M, Schiefer J, Stienen A, Blaum M, Ritter K, Hausler M. Expanding the spectrum of neurological disease associated with Epstein- Barr virus activity. Eur J Clin Microbiol Infect Dis 2011;30:1561-1569. https://doi.org/10.1007/s10096-011-1261-7
- Hausler M, Ramaekers VT, Doenges M, Schweizer K, Ritter K, Schaade L. Neurological complications of acute and persistent Epstein-Barr virus infection in paediatric patients. J Med Virol 2002;68:253-263. https://doi.org/10.1002/jmv.10201
- Kennedy M, Apostolova M. A rare case of infectious mononucleosis complicated by Guillain-Barre syndrome. Neurol Int 2013;5:20-22. https://doi.org/10.4081/ni.2013.e20
- Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med 2012;366:2294-2304. https://doi.org/10.1056/NEJMra1114525
- Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27 Suppl:S21-S24. https://doi.org/10.1002/ana.410270707
- de Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol 2012;1:31-43. https://doi.org/10.5501/wjv.v1.i1.31
- Portegies P, Corssmit N. Epstein-Barr virus and the nervous system. Curr Opin Neurol 2000;13:301-304. https://doi.org/10.1097/00019052-200006000-00012
- Jacobs B, Rothbarth P, van der Meche F, Herbrink P, Schmitz P, de Klerk M, et al. The spectrum of antecedent infections in Guillain-Barre syndrome a case-control study. Neurology 1998;51:1110-1115. https://doi.org/10.1212/WNL.51.4.1110
- Torre D, Tambini R. Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis 1999;31:543-547. https://doi.org/10.1080/00365549950164409
- Tynell E, Aurelius E, Brandell A, Julander I, Wood M, Yao QY, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 1996;174:324-331. https://doi.org/10.1093/infdis/174.2.324